SHP2 is a positive regulator of the EGFR-dependent Ras/MAPK
pathway.
It dephosphorylates a regulatory phosphorylation site in EGFR that
serves as the binding site to RasGAP (RASA1 or p120RasGAP). RASA1
is activated by binding to the EGFR phosphate group. Active RASA1
deactivates Ras by hydrolyzing Ras-bound GTP to GDP. Thus, SHP2 dephosphorylation
of EGFR effectively prevents RASA1-mediated deactivation of Ras, thereby
stimulating proliferation. Despite knowledge of this vital regulation
in cell life, mechanistic in-depth structural understanding of the
involvement of SHP2, EGFR, and RASA1 in the Ras/MAPK pathway has largely
remained elusive. Here we elucidate the interactions, the factors
influencing EGFR’s recruitment of RASA1, and SHP2’s
recognition of the substrate site in EGFR. We reveal that RASA1 specifically
interacts with the DEpY992LIP motif in EGFR featuring a
proline residue at the +3 position C-terminal to pY primarily through
its nSH2 domain. This interaction is strengthened by the robust attraction
of two acidic residues, E991 and D990, of EGFR to two basic residues
in the BC-loop near the pY-binding pocket of RASA1’s nSH2.
In the stable precatalytic state of SHP2 with EGFR (DADEpY992LIPQ), the E-loop of SHP2’s active site favors the interaction
with the (−2)-position D990 and (−4)-position D988 N-terminal
to pY992 in EGFR, while the pY-loop constrains the (+4)-position Q996
C-terminal to pY992. These specific interactions not only provide
a structural basis for identifying negative regulatory sites in other
RTKs but can inform selective, high-affinity active-site SHP2 inhibitors
tailored for SHP2 mutants.